Melatonin and hypertension: a possible role in combination therapy


Cite item

Full Text

Abstract

This literature review gives the results of clinical trials studying the association of the level of endogenous melatonin and blood pressure (BP), the effects of exogenous melatonin on BP (particularly at night) in relation to the used rapid- or controlled-release formulation of melatonin.

About the authors

A V Budnevsky

ФГБОУ ВО «Воронежский государственный медицинский университет им. Н.Н. Бурденко» Минздрава России

Воронеж, Россия

E S Ovsyannikov

ФГБОУ ВО «Воронежский государственный медицинский университет им. Н.Н. Бурденко» Минздрава России

Воронеж, Россия

N V Rezova

ФГБОУ ВО «Воронежский государственный медицинский университет им. Н.Н. Бурденко» Минздрава России

Воронеж, Россия

Ya S Shkatova

ФГБОУ ВО «Воронежский государственный медицинский университет им. Н.Н. Бурденко» Минздрава России

Воронеж, Россия

References

  1. Чазова И.Е., Ратова Л.Г., Бойцов С.А. и др. Диагностика и лечение артериальной гипертензии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов. Системные гипертензии. 2010;3:5-26.
  2. Cuspidi C, Meani S, Salerno M, et al. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens. 2004;22(11):273-280. https://doi.org/10.1097/00004872-200402000-00010
  3. Fagard RH, Thijs L, Staessen JA at al. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J Hum Hypertens. 2009;23(10):645-653. https://doi.org/10.1038/jhh.2009.9
  4. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2006;46(1):156-161. https://doi.org/10.1161/01.hyp.0000170138.56903.7a
  5. Комаров Ф.И., Рапопорт С.И., Малиновская Н.К. и др. Мелатонин в норме и патологии. М.: 2004;308.
  6. Sewerynek E. Melatonin and the cardiovascular system. Neuro Endocrinol Lett. 2002;Suppl.23:79-83.
  7. Cagnacci A, Arangino S, Angiolucci M, Maschio E, Longu G, Melis G. Potentially beneficial cardiovascular effects of melatonin administration in women. J Pineal Res. 1997;22(1):16-19. https://doi.org/10.1111/j.1600-079x.1997.tb00297.x
  8. Arangino S, Cagnacci A, Angiolucci M, et al. Effects of melatonin on vascular reactivity, catecholamine levels and blood pressure in healthy men. Am J Cardiol. 1999;83(9):1417-1419. https://doi.org/10.1016/s0002-9149(99)00112-5
  9. Cagnacci A, Arangino S, Angiolucci M, Maschio E, Melis GB. Influences of melatonin administration on the circulation of women. Am J Physiol. 1998;274(2 Pt 2):335-338.
  10. Gonzalez Rodriguez E, Hernandez A, Dibner C. Arterial blood pressure circadian rhythm: significance and clinical implications. Rev Med Suisse. 2012;8(353):1709-1714.
  11. Jonas M, Garfinkel D, Zisapel N, Laudon M, Grossman E. Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press. 2003;12(1):19-24. https://doi.org/10.1097/00004872-200006001-00120
  12. Zeman M, Dulkova K, Bada V, Herichova I. Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. Life Sci. 2005;76(16):1795-1803. https://doi.org/10.1016/j.lfs.2004.08.034
  13. Brugger P, Markti W, Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet. 1995;345(8962):1408. https://doi.org/10.1016/s0140-6736(95)92600-3
  14. Sakotnik A, Liebmann PM, Stoschitzky K, et al. Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J. 1999;20(18):1314-1317. https://doi.org/10.1053/euhj.1999.1527
  15. Cagnacci A, Arangino S, Angiolucci M, Maschio E, Longu G, Melis G. Potentially beneficial cardiovascular effects of melatonin administration in women. J Pineal Res. 1997;22(1):16-19. https://doi.org/10.1111/j.1600-079x.1997.tb00297.x
  16. Ray CA. Melatonin attenuates sympathetic nerve responses to orthostatic stress in humans. J Physiol. 2003;15:555(Pt 3):1043-1048. https://doi.org/10.1113/jphysiol.2003.043182
  17. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation. 1990;81(2):700-702. https://doi.org/10.1161/01.cir.81.2.700
  18. Hojo Y, Noma S, Ohki T, Nakajima H, Satoh Y. Autonomic nervous system activity in essential hypertension: A comparison between dippers and non-dippers. J Hum Hypertens. 1997;11(10):665-671. https://doi.org/10.1038/sj.jhh.1000515
  19. van der Zwan LP, Scheffer PG, Teerlink T. Reduction of myeloperoxidase activity by melatonin and pycnogenol may contribute to their blood pressure lowering effect. Hypertension. 2010; 56(3):e34. https://doi.org/10.1161/hypertensionaha.110.158170
  20. Kostovski E, Dahm AE, Iversen N, et al. Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium. Blood Coagul Fibrinolysis. 2011;22(4):254-259. https://doi.org/10.1097/mbc.0b013e3283442ce2
  21. Mattace-Raso FU, Hofman A, Verwoert GC, et al. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: Establishing normal and reference values. Eur Heart J. 2010;31(19):2338-2350. https://doi.org/10.1093/eurheartj/ehq165
  22. Silva JA, Barbosa L, Bertoquini S, Maldonado J, Polonia J. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients. Rev Port Cardiol. 2004;23(12):1533-1547.
  23. Syrseloudis D, Tsioufis C, Andrikou I, et al. Association of nighttime hypertension with central arterial stiffness and urinary albumin excretion in dipper hypertensive subjects. Hypertens Res. 2011;34(1):120-125. https://doi.org/10.1038/hr.2010.192
  24. Yildiz M, Akdemir O. Assessment of the effects of physiological release of melatonin on arterial distensibility and blood pressure. Cardiol Young. 2009;19(2):198-203. https://doi.org/10.1017/s1047951109003692
  25. Yildiz M, Sahin B, Sahin A. Acute effects of oral melatonin administration on arterial distensibility, as determined by carotid-femoral pulse wave velocity, in healthy young men. Exp Clin Cardiol. 2006; 11(4):311-313.
  26. Le Bars D, Thivolle P, Vitte PA, et al. PET and plasma pharmacokineic studies after bolus intraenous administration of [11 c] melatonin in humans. Int J Radiat Appl Instrum. 1991;18(3):357-362.
  27. Waldhauser F, Waldhauser M, Lieberman HR, Deng MH, Lynch HJ, Wurtman RJ. Bioavailability of oral melatonin in humans. Neuroendocrinology. 2008;39(4):307-313. https://doi.org/10.1159/000123997
  28. Aldhous M, Franey C, Wright J, Arendt J. Plasma concentrations of melatonin in man following oral absorption of different preparations. Br J Clin Pharmacol. 1985;19(4):517-521. https://doi.org/10.1111/j.1365-2125.1985.tb02679.x
  29. Rachmani R, Shenhav G, Slavachevsky I, Levy Z, Ravid M. Use of a mild sedative helps to identify true non-dippers by ABPM: A study in patients with diabetes mellitus and hypertension. Blood Press Monit. 2004;9(2):65-69. https://doi.org/10.1097/00126097-200404000-00002
  30. McCann CC, Quera-Salva MA, Boudet J, et al. Effect of zolpidem during sleep on ventilation and cardiovascular variables in normal subjects. Fundam Clin Pharmacol. 1993;7(6):305-310. https://doi.org/10.1111/j.1472-8206.1993.tb00244.x
  31. Stergiou GS, Vemmos KN, Pliarchopoulou KM, Synetos AG, Roussias LG, Mountokalakis TD. Parallel morning and evening surge in stroke onset, blood pressure, and physical activity. Stroke. 2002;33(6): 1480-1486. https://doi.org/10.1161/01.str.0000016971.48972.14
  32. Obayashi K, Saeki K, Tone N et al. Relationship between melatonin secretion and nighttime blood pressure in elderly individuals with and without antihypertensive treatment: a cross-sectional study of the HEIJO-KYO cohort. Hypertens Res. 2014 Oct;37(10): 908-913. https://doi.org/10.1038/hr.2014.99
  33. Obayashi K, Saeki K, Kurumatani N. Asymmetric dimethylarginine attenuates the association of melatonin secretion with night-time blood pressure and dipping in elderly individuals. Circ J. 2014;78(12):2908-2914. https://doi.org/10.1253/circj.cj-14-0613
  34. Forman JP, Curhan GC, Schernhammer ES. Urinary melatonin and risk of incident hypertension among young women. J Hypertens. 2010 Mar;28(3):446-451. https://doi.org/10.1097/hjh.0b013e3283340c16
  35. Cui HW, Zhang ZX, Gao MT et al. Circadian rhythm of melatonin and blood pressure changes in patients with essential hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2008;36(1):20-23.
  36. Cavallo A, Daniels SR, Dolan LM, Khoury JC, Bean JA. Blood pressure response to melatonin in type 1 diabetes. Pediatr Diabetes. 2004;5(1): 26-31. https://doi.org/10.1111/j.1399-543x.2004.00031.x
  37. Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, Buijs RM. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension. 2004; 43(2):192-197. https://doi.org/10.1161/01.hyp.0000113293.15186.3b
  38. Lusardi P, Piazza E, Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: A 24-hour study. Br J Clin Pharmacol. 2000;49(5):423-427. https://doi.org/10.1046/j.1365-2125.2000.00195.x
  39. Grossman E, Laudon M, Yalcin R, et al. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med. 2006;119(10):898-902. https://doi.org/10.1016/j.amjmed.2006.02.002
  40. Lusardi P, Preti P, Savino S, Piazza E, Zoppi A, Fogari R. Effect of bedtime melatonin ingestion on blood pressure of normotensive subjects. Blood Press Monit. 1997;2(2):99-103.
  41. Rechcinski T, Trzos E, Wierzbowska-Drabik K, Krzeminska-Pakula M, Kurpesa M. Melatonin for nondippers with coronary artery disease: Assessment of blood pressure profile and heart rate variability. Hypertens Res. 2010;33(1):56-61. https://doi.org/10.1038/hr.2009.174
  42. Cagnacci A, Cannoletta M, Renzi A, Baldassari F, Arangino S, Volpe A. Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens. 2005;18(12 Pt 1):1614-1618. https://doi.org/10.1016/j.amjhyper.2005.05.008
  43. Tan DX, Manchester LC, Reiter RJ. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res. 1998;25(3):184-91. https://doi.org/10.1111/j.1600-079X.1998.tb00558.x
  44. Grossman E, Laudon M, Zisapel N. Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials.Vasc. Health Risk Manag. 2011;7:577-584. https://doi.org/10.2147/vhrm.s24603
  45. De la Sierra A, Redon J, Banegas JR, et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension. 2009;53(3):466-472. https://doi.org/10.1161/hypertensionaha.108.124008
  46. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of circadian time of hypertension treatment on cardiovascular risk: Results of the MAPEC study. Chronobiol Int. 2010;27(8):1629-1651. https://doi.org/10.3109/07420528.2010.510230
  47. Buscemi N, Vandermeer B, Hooton N, et al. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med. 2005;20(12):1151-1158. https://doi.org/10.1136/bmj.38731.532766.f6
  48. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282(6):539-546. https://doi.org/10.1001/jama.282.6.539
  49. Mozdzan M, Chalubinski M et al. The effect of melatonin on circadian blood pressure in patients with type 2 diabetes and essential hypertension. Arch Med Sci. 2014;10(4):669-675. https://doi.org/10.5114/aoms.2014.44858

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies